“AbbVie confirms its interest in three major therapeutic indications in the field of ophthalmology: in dry eye and in retinal diseases and in glaucoma and in particular in glaucoma. It is a rich portfolio that looks at the patient’s disease experience, whether with diabetic retinopathy, glaucoma or dry eye disease. Having 360 degree solutions for the organ”. Thus, Annalisa Iezzi, Medical Director of AbbVie Italia, speaking about maculopathy, diabetic retinopathy, glaucoma and AbbVie’s commitment in this regard.
#Salute #Iezzi #AbbVie #rich #portfolio #solutions #protect #eyesight
